Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5613794 | Journal of the American Society of Hypertension | 2016 | 8 Pages |
Abstract
We previously reported interferon regulatory factor (IRF) 1 plays physiological roles in “growth”-regulated angiotensin II type 2 (AT2) receptor expression in fibroblasts. Here, we investigated whether IRF-1 is involved in attenuation of vascular remodeling in association with AT2 receptor upregulation. Neointimal area in injured artery after 14 days of cuff placement was significantly increased in IRF-1 knockout mice (IRF-1KO) and AT2 receptor knockout mice (AT2KO) compared with wild-type mice (WT: C57BL/6J). Treatment with compound 21 attenuated neointima formation in both WT and IRF-1KO. AT2 receptor mRNA expression after 7 days of cuff placement was significantly decreased in IRF-1KO compared with WT; however, IRF-1 expression did not differ between AT2KO and WT. Apoptotic changes in injured artery after 14 days of cuff placement were significantly attenuated in IRF-1KO, with a decrease in interleukin-1β-converting enzyme and inducible nitric oxide synthase mRNA levels. These results indicate IRF-1 is one of the key transcriptional factors for the prevention of neointimal formation involving AT2 receptors.
Related Topics
Life Sciences
Neuroscience
Endocrine and Autonomic Systems
Authors
Hirotomo MS, Masaki MD, PhD, Jun MD, PhD, Harumi MS, Li-Juan MD, PhD, Jun PhD, Masatsugu MD, PhD,